Commentary by Alex Berenson
Best news I’ve seen all month. From Alex Berenson at alexberenson.substack.com:
Even Travis Kelce’s shuckin’ and grinnin’ for Pfizer can’t save these shots. People know they don’t stop infection, they know the side effects are often brutal, and they don’t want them.
(I owe you more on Israel, but it feels like we all need a break from the awfulness. Some good news instead…)
RIP, mRNA.
The once-heralded vaccine biotechnology officially died last week after a long illness. Maybe myocarditis or Type 1 diabetes. Could have been a shingles infection. Or possibly just a mix of uselessness and nasty side effects.
Dr. Mandy Cohen, the director of the Centers for Disease Control, accidentally announced mRNA’s passing on Friday on X (aka Twitter). Wearing a blue dress and her trademark vapid smile, Dr. Cohen admitted barely 1 out of 50 Americans have received the new mRNA Omicron booster.
Hours later, Pfizer confirmed the death, saying it will write off nearly $1 billion in mRNA jab inventory because of weak demand. Pfizer expects the market for shots to be one-third smaller than it predicted just weeks ago – though its new estimate still appears too high.
Okay, mRNAs aren’t actually dead. But even as the CDC and vaccine manufacturers to promote the new booster with massive ad campaigns, demand has collapsed. And Wall Street has noticed.
Since the announcements Friday, shares in Moderna – which unlike Pfizer has no other products and relies only on mRNA Covid shots for revenue – have fallen almost 15 percent. Amazingly, Moderna is now off 80 percent from its peak in summer 2021 (its highest weekly close ever came Sept. 10, 2021, one day after President Biden announced Covid jab workplace mandates).
The views and opinions expressed in this commentary are those of the author and do not reflect the official position of Citizens Journal
TELL YOUR FRIENDS ABOUT CITIZENS JOURNAL Please keep us publishing – DONATE
